Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Oxysterols receptor LXR-alpha | ||
Ligand | BDBM304622 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Human LXRalpha and LXRbeta Coactivator Recruitment FRET Assay | ||
EC50 | 287±n/a nM | ||
Citation | Claremon, DA; Dong, C; Fan, Y; Leftheris, K; Lotesta, SD; Singh, SB; Tice, CM; Zhao, W; Zheng, Y; Zhuang, L Piperazine derivatives as liver X receptor modulators US Patent US10144715 Publication Date 12/4/2018 | ||
More Info.: | Get all data from this article, Assay Method | ||
Oxysterols receptor LXR-alpha | |||
Name: | Oxysterols receptor LXR-alpha | ||
Synonyms: | LXRA | Liver X Receptor alpha (LXR-alpha) | Liver X receptor alpha | Liver X receptor alpha (LXRA) | Liver X receptor alpha (NR1H3) | Liver X, LXR alpha | NR1H3 | NR1H3_HUMAN | Nuclear orphan receptor LXR-alpha | Nuclear receptor subfamily 1 group H member 3 | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 50403.85 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q13133 | ||
Residue: | 447 | ||
Sequence: |
| ||
BDBM304622 | |||
n/a | |||
Name | BDBM304622 | ||
Synonyms: | (S)-1-(((1s,4R)-4-(difluoromethyl)cyclohexyl)methyl)-4-(3-(methylsulfonyl)phenyl)-2-phenylpiperazine | US10144715, Compound 48-17 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H30F2N2O3S | ||
Mol. Mass. | 476.579 | ||
SMILES | CS(=O)(=O)c1cccc(c1)N1CCN([C@H](C1)c1ccccc1)C(=O)C1CC[C@@H](CC1)C(F)F |r,wD:14.17,27.33,(2.97,10.89,;3.74,9.56,;5.07,10.33,;5.07,8.79,;2.97,8.22,;3.74,6.89,;2.97,5.56,;1.43,5.56,;.66,6.89,;1.43,8.22,;-.88,6.89,;-1.65,8.22,;-3.19,8.22,;-3.96,6.89,;-3.19,5.56,;-1.65,5.56,;-3.96,4.22,;-5.5,4.22,;-6.27,2.89,;-5.5,1.55,;-3.96,1.55,;-3.19,2.89,;-5.5,6.89,;-6.27,5.56,;-6.27,8.22,;-7.81,8.22,;-8.58,9.56,;-7.81,10.89,;-6.27,10.89,;-5.5,9.56,;-8.58,12.22,;-10.12,12.22,;-7.81,13.56,)| | ||
Structure |